Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone
isopropyl, was marketed under the trade name Rescula for the management of ...
Jan 3, 2013 ... Rescula (unoprostone isopropyl) Ophthalmic Solution 0.15% is a synthetic
docosanoid. Unoprostone isopropyl has the chemical name ...
Medscape - Indication-specific dosing for Rescula (unoprostone ophthalmic),
frequency-based adverse effects, comprehensive interactions, contraindications,
Easy to read patient leaflet for unoprostone drops. Includes indications, proper
use, special instructions, precautions, and possible side effects.
Aug 15, 2013 ... Unoprostone Ophthalmic: learn about side effects, dosage, special precautions,
and more on MedlinePlus.
May 15, 2013 ... Unoprostone was developed from a prostaglandin metabolite, but the compound
itself was considered to be a docosanoid with properties ...
NDA 21-214 Rescula (unoprostone isopropyl ophthalmic solution) 0.15% ...
Unoprostone Isopropyl is a docosanoid, a structural analogue of an inactive ...
Consumer information about the medication UNOPROSTONE - OPHTHALMIC (
Rescula), includes side effects, drug interactions, recommended dosages, and ...
Dec 7, 2012 ... Rescula (unoprostone isopropyl ophthalmic solution). 0.15% is indicated for the
lowering of intraocular pressure in patients with open-angle ...
13,14-dihydro-15-keto-20-ethyl Prostaglandin F2α isopropyl ester; Rescula.
Unoprostone isopropyl ester (Rescula) is the clinically approved, prodrug form of